72.11.Z - Scientific research and development activities
21.10.Z - Manufacture of basic pharmaceutical products
26.30.Z - Manufacture of (tele)communication equipment
26.51.Z - Manufacture of measuring, controlling, and navigation instruments
26.70.Z - Manufacture of optical instruments, magnetic and optical information carriers, and photographic equipment
32.50.Z - Production of medical devices, instruments, and products, including dental products
62.01.Z - Activities related to programming, IT consulting, and related activities
70.22.Z - Head office activities and management consultancy
72.19.Z - Scientific research and development activities
77.40.Z - Leasing of intellectual property and similar products, excluding works protected by copyright
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,5 | -3,6 | -7,4 | -108 |
EBITDA | -0,7 | -2,5 | -6,1 | -141,9 |
Short time liabilities | 0,4 | 0,9 | 0,6 | -37 |
Equity capital | 9,9 | 6,1 | 4,6 | -24,8 |
Operating profit (EBIT) | -0,9 | -2,7 | -6,6 | -145,8 |
Assets | 10,3 | 7,3 | 5,3 | -28,1 |
Net profit (loss) | -1,5 | -3,8 | -7,2 | -87,8 |
Cash | 8,3 | 0,8 | 1 | 32 |
Net income from sale | 0,5 | 0,8 | 0 | -97,4 |
Liabilities and provisions for liabilities | 0,4 | 1,2 | 0,7 | -44,1 |
Working assets | 9,1 | 4,3 | 2,2 | -48,4 |
Depreciation | 0,2 | 0,2 | 0,6 | 195 |
% | % | % | p.p. | |
Profitability of capital | -14,8 | -63,2 | -158 | -94,8 |
Equity capital to total assets | 95,8 | 82,9 | 86,7 | 3,8 |
Gross profit margin | -327 | -422,8 | -33 532,1 | -33 109,3 |
EBITDA Margin | -158,6 | -296,3 | -27 327,5 | -27 031,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 292 | 399 | 9586 | 9187 |
Current financial liquidity indicator | 21.371219635009766 | 4.467716217041016 | 3.3785414695739746 | -1,1 |
Net dept to EBITDA | 11.60043716430664 | 0.3086017966270447 | 0.16837914288043976 | -0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane